NEW YORK (GenomeWeb) – Focus Diagnostics, a Quest Diagnostics subsidiary, has received 510(k) clearance from the US Food and Drug Administration for additional strains on its Simplexa molecular test kit for influenza and respiratory syncytial virus.

The new clearance adds 46 additional strains of influenza A and B— including 20 avian influenza A and two swine influenza virus — and seven RSV strains. The test now detects a total of 92 strains of flu and RSV, which it said in a statement is more than any other FDA-cleared molecular test kit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.

Sponsored by

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.